TWI341208B - - Google Patents

Info

Publication number
TWI341208B
TWI341208B TW092127646A TW92127646A TWI341208B TW I341208 B TWI341208 B TW I341208B TW 092127646 A TW092127646 A TW 092127646A TW 92127646 A TW92127646 A TW 92127646A TW I341208 B TWI341208 B TW I341208B
Authority
TW
Taiwan
Application number
TW092127646A
Other versions
TW200407160A (en
Inventor
Hideki Matsui
Original Assignee
Hideki Matsui
Japan Science & Tech Agency
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hideki Matsui, Japan Science & Tech Agency filed Critical Hideki Matsui
Publication of TW200407160A publication Critical patent/TW200407160A/zh
Application granted granted Critical
Publication of TWI341208B publication Critical patent/TWI341208B/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10—Peptides having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones
    • A61P5/22—Drugs for disorders of the endocrine system of the parathyroid hormones for decreasing, blocking or antagonising the activity of calcitonin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Hospice & Palliative Care (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Psychology (AREA)
  • Psychiatry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pain & Pain Management (AREA)
TW092127646A 2002-10-08 2003-10-06 Inhibitors for continuous activation of calcineurin TW200407160A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2002294815 2002-10-08

Publications (2)

Publication Number Publication Date
TW200407160A TW200407160A (en) 2004-05-16
TWI341208B true TWI341208B (zh) 2011-05-01

Family

ID=32089192

Family Applications (1)

Application Number Title Priority Date Filing Date
TW092127646A TW200407160A (en) 2002-10-08 2003-10-06 Inhibitors for continuous activation of calcineurin

Country Status (7)

Country Link
US (1) US7183375B2 (zh)
EP (1) EP1552847A4 (zh)
JP (1) JP4642469B2 (zh)
KR (1) KR100833728B1 (zh)
CN (1) CN100340288C (zh)
TW (1) TW200407160A (zh)
WO (1) WO2004032955A1 (zh)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5898304B2 (ja) * 2011-04-25 2016-04-06 シャンドン・ヴィジェネ・バイオサイエンシズ・インコーポレーテッド ＮＦ−κＢ活性上昇に関連する疾患を治療するための医薬を製造するためのカルシニューリン調節因子１の使用
CN117511882A (zh) * 2022-08-03 2024-02-06 浙江大学医学院附属第一医院 一种通用型免疫效应细胞及其制备方法和应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2810995A1 (fr) * 2000-06-29 2002-01-04 Exonhit Therapeutics Sa Compositions et methodes pour le traitement ou la detection de pathologies neurodegeneratives

Also Published As

Publication number Publication date
US7183375B2 (en) 2007-02-27
TW200407160A (en) 2004-05-16
KR100833728B1 (ko) 2008-05-29
WO2004032955A1 (ja) 2004-04-22
EP1552847A1 (en) 2005-07-13
EP1552847A4 (en) 2009-10-28
JP4642469B2 (ja) 2011-03-02
CN100340288C (zh) 2007-10-03
CN1691960A (zh) 2005-11-02
JPWO2004032955A1 (ja) 2006-02-09
KR20050065581A (ko) 2005-06-29
US20060177431A1 (en) 2006-08-10

Similar Documents

Publication Publication Date Title
BE2019C547I2 (zh)
BE2019C510I2 (zh)
BE2018C021I2 (zh)
BE2017C049I2 (zh)
BE2017C005I2 (zh)
BE2016C069I2 (zh)
BE2016C040I2 (zh)
BE2016C013I2 (zh)
BE2018C018I2 (zh)
BE2014C051I2 (zh)
BE2014C041I2 (zh)
BE2011C038I2 (zh)
IN2007CH00514A (zh)
JP2003234757A5 (zh)
BRPI0215435A2 (zh)
JP2002365377A5 (zh)
ECSDI024335S (zh)
TWI341208B (zh)
BR0315835A2 (zh)
JP2003206015A5 (zh)
JP2003226575A5 (zh)
JP2003241950A5 (zh)
HU0202837D0 (zh)
AU2001278584A1 (zh)
AU2001277216A1 (zh)

Legal Events

Date Code Title Description
MM4A Annulment or lapse of patent due to non-payment of fees